OTCMEVIO
Market cap19kUSD
Dec 23, Last price
0.00USD
1D
0.00%
Jan 2017
-100.00%
Name
EVIO Inc
Chart & Performance
Profile
EVIO, Inc., together with its subsidiaries, provides analytical testing and advisory services to cannabis industry in the United States. The company's consulting services include advisory, product formulation, and licensing and compliance services. It also offers various testing services comprise cannabinoid potency testing, terpene analysis, pesticide testing, residual solvent screening, visual inspections, biological contaminant testing, and other services. EVIO, Inc. is headquartered in Henderson, Nevada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|
2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | 2015‑09 | |
Income | ||||||||
Revenues | 1,590 -32.71% | |||||||
Cost of revenue | 1,065 | |||||||
Unusual Expense (Income) | ||||||||
NOPBT | 525 | |||||||
NOPBT Margin | 33.02% | |||||||
Operating Taxes | (553) | |||||||
Tax Rate | ||||||||
NOPAT | 1,078 | |||||||
Net income | 48 -104.97% | |||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
Debt | ||||||||
Debt current | 2,597 | |||||||
Long-term debt | 5,167 | |||||||
Deferred revenue | ||||||||
Other long-term liabilities | (329) | |||||||
Net debt | 7,759 | |||||||
Cash flow | ||||||||
Cash from operating activities | (652) | |||||||
CAPEX | (67) | |||||||
Cash from investing activities | 715 | |||||||
Cash from financing activities | (73) | |||||||
FCF | 3,877 | |||||||
Balance | ||||||||
Cash | 5 | |||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | (47,143) | |||||||
Invested Capital | 42,319 | |||||||
ROIC | 2.44% | |||||||
ROCE | ||||||||
EV | ||||||||
Common stock shares outstanding | 1,605,511 | |||||||
Price | 0.00 -87.50% | |||||||
Market cap | 161 -87.50% | |||||||
EV | 8,077 | |||||||
EBITDA | 986 | |||||||
EV/EBITDA | 8.19 | |||||||
Interest | 757 | |||||||
Interest/NOPBT | 144.19% |